Plain-English translation of NCT07142707 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new medication called designed to help with weight loss in adults with obesity. The study will carefully measure how safe the medication is, how your body processes it, and how it affects your weight. About 124 people will participate, with some receiving the medication and others receiving a placebo (a dummy pill with no active ingredient).
Current weight loss treatments don't work well enough for everyone, and doctors need new options to help people manage obesity and its health complications. This trial is one of the first steps in testing whether this medication could be a helpful new treatment option.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times over several weeks. In the first part of the study, some participants will receive a single dose of the medication, while others receive a placebo. In later parts, participants will receive multiple doses over time so researchers can see how your body responds. At each visit, you'll have blood tests, vital signs checked, and answer questions about how you're feeling. The study team will carefully monitor you for any side effects throughout the trial.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States